Chronic kidney disease market to witness slight decline by 2017 The Pharma Letter The value of the chronic kidney disease market could drop 2.5% between 2012 and 2017 due to the loss of patents for major brands and the changing reimbursement environment, says research and consulting firm GlobalData. According to the company's ... |
